CVRx

Related Content

Videos | Cardiovascular Clinical Studies
DAIC Thought Leadership Series: The Importance of Inclusion in Clinical Trials

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
arrow
Philip B. Adamson, MD, MSc, FACC, FESC, FRCP (Ed) has been appointed as Chief Medical Officer
News | Cardiovascular Business
CVRx Announces Key Senior Leadership Team Hires

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
arrow
Investigational technology designed for patients undergoing emerging large bore percutaneous catheter-based venous interventional procedures
News | Cardiovascular Clinical Studies
CVRx Announces Availability of Additional Data Supporting Long-term Benefits of Barostim

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
arrow
The full results of BeAT-HF, including a number of additional analyses and endpoints, will be submitted by the executive steering committee for publication in one or more peer-reviewed journals
News | Heart Failure
Totality of Evidence from BeAT-HF Study Shows CVRx’s Barostim Provides Long-term Benefits for Patients with Heart Failure

March 21, 2023 — CVRx, Inc., a commercial-stage medical device company focused on developing, manufacturing and ...

Home March 21, 2023
arrow
Heart failure patients implanted with Barostim can now receive conditional MRI scans
News | Magnetic Resonance Imaging (MRI)
CVRx Receives MR-conditional Labeling Approval for its Barostim Heart Failure System

May 9, 2022 — CVRx, Inc., developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of ...

Home May 09, 2022
arrow
FDA Approves Barostim Neo System for Advanced Heart Failure Patients. Similar to a pacemaker, the Barostim Neo System uses a pulse generator implanted below the collar bone with a lead that attaches to the carotid artery in the neck. It delivers electrical impulses to baroreceptors in the neck, which sense how blood is flowing through the carotid arteries and relays information to the brain. The brain, in turn, sends signals to the heart and blood vessels that relax the blood vessels.
Technology | Heart Failure
FDA Approves Pacemaker-like Device to Treat Heart Failure

August 19, 2019 — The U.S. Food and Drug Administration (FDA) granted market clearance the Barostim Neo System for the ...

Home August 19, 2019
arrow
CVRx, Barostim therapy, heart failure, trial, ESC-Heart Failure, Muller-Ehmsen
News
CVRx Barostim Therapy Clinical Trial Results Presented at ESC-Heart Failure Conference

May 28, 2015 — CVRx Inc. announced that positive results from the 'Barostim Therapy for Heart Failure' randomized ...

Home May 28, 2015
arrow
heart failure, BAT, baroreflex activation therapy, William Abraham, CVRx
Feature
Study Finds Baroreflex Activation Therapy Effectively Treats Heart Failure

March 23, 2015 — Results of a clinical trial announced at the American College of Cardiology Annual Scientific Session ...

Home March 23, 2015
arrow
CVRx, Barostim neo Legacy System, pacemaker, hypertension, FDA, HDE
Technology
FDA Grants HDE For Pacemaker That Regulates Hypertension

January 19, 2015 — The U.S. Food and Drug Administration (FDA) has granted a humanitarian device exemption for the CVRx ...

Home January 19, 2015
arrow
hypertension therapies cvrx barostim neo therapy
News
Barostim Therapy Projected to be Cost-Effective in Treating Resistant Hypertension

January 10, 2014 — CVRx Inc. announced findings from a health-economic analysis published in the Journal of Hypertension ...

Home January 10, 2014
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now